Human Galectin-7 PharmaGenie ELISA Kit (SBRS0606)

Galectin-7 is a 15 kDa beta-galactoside-binding lectin with established roles in epithelial cell differentiation, apoptosis, and tumor progression in squamous cell carcinomas and breast cancer. The Assay Genie Human Galectin-7 PharmaGenie ELISA Kit quantifies this lectin in human cell culture supernatants, plasma, and serum samples for research use only. Part of the PharmaGenie reagent line, the kit supports in vitro investigation of galectin-7 expression across cell biology and disease models. The 96-assay format delivers sufficient reagents for standard curves and multiple experimental replicates, enabling biomarker and pathway studies in oncology and dermatology research.